{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T15:20:58Z","timestamp":1781968858225,"version":"3.54.5"},"reference-count":273,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2025,10,31]]},"DOI":"10.5582\/bst.2025.01120","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T22:07:23Z","timestamp":1752962843000},"page":"521-544","source":"Crossref","is-referenced-by-count":1,"title":["Therapeutic potentials of mesenchymal stem cell-derived exosomes for major solid malignancies: A narrative systematic review"],"prefix":"10.5582","volume":"19","author":[{"given":"Xiujuan","family":"Wang","sequence":"first","affiliation":[{"name":"Technology Department, Tianjin Everunion Biotechnology Co., Ltd., Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Pan","sequence":"additional","affiliation":[{"name":"Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital Eye Center, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China."},{"name":"Beijing Key Laboratory of Intelligent Diagnostic Technology and Devices for Major Blinding Eye Diseases, Tsinghua Medicine, Tsinghua University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nian","family":"Liu","sequence":"additional","affiliation":[{"name":"Technology Department, Tianjin Everunion Biotechnology Co., Ltd., Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunan","family":"Dai","sequence":"additional","affiliation":[{"name":"Beijing Key Laboratory of Intelligent Diagnostic Technology and Devices for Major Blinding Eye Diseases, Tsinghua Medicine, Tsinghua University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[{"name":"Technology Department, Tianjin Everunion Biotechnology Co., Ltd., Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital Eye Center, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, China."},{"name":"Beijing Key Laboratory of Intelligent Diagnostic Technology and Devices for Major Blinding Eye Diseases, Tsinghua Medicine, Tsinghua University, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Xu","sequence":"additional","affiliation":[{"name":"Technology Department, Tianjin Everunion Biotechnology Co., Ltd., Beijing, China."},{"name":"Beijing Key Laboratory of Intelligent Diagnostic Technology and Devices for Major Blinding Eye Diseases, Tsinghua Medicine, Tsinghua University, Beijing, China."},{"name":"HELP Therapeutics Co., Ltd., Nanjing, China."},{"name":"Chongqing Institute of Health Resources Innovation, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Najafi M, Majidpoor J, Toolee H, Mortezaee K. The current knowledge concerning solid cancer and therapy. J Biochem Mol Toxicol. 2021; 35:e22900.","DOI":"10.1002\/jbt.22900"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Tr\u00e9dan O, Galmarini CM, Patel K, Tannock IF. Drug resistance and the solid tumor microenvironment. J Natl Cancer Inst. 2007; 99:1441-1454.","DOI":"10.1093\/jnci\/djm135"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Garg P, Malhotra J, Kulkarni P, Horne D, Salgia R, Singhal SS. Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells. Cancers. 2024; 16:2478.","DOI":"10.3390\/cancers16132478"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Maeda H, Khatami M. Analyses of repeated failures in cancer therapy for solid tumors: poor tumor-selective drug delivery, low therapeutic efficacy and unsustainable costs. Clin Transl Med. 2018; 7:11.","DOI":"10.1186\/s40169-018-0185-6"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Graham K, Unger E. Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment. Int J Nanomedicine. 2018; 6049-6058.","DOI":"10.2147\/IJN.S140462"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Bukowski K, Kciuk M, Kontek R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy. Int J Mol Sci. 2020; 21.","DOI":"10.3390\/ijms21093233"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Moradi Kashkooli F, Soltani M. Evaluation of solid tumor response to sequential treatment cycles <i>via<\/i> a new computational hybrid approach. Sci Rep. 2021; 11:21475.","DOI":"10.1038\/s41598-021-00989-x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zeien J, Qiu W, Triay M, Dhaibar HA, Cruz-Topete D, Cornett EM, Urits I, Viswanath O, Kaye AD. Clinical implications of chemotherapeutic agent organ toxicity on perioperative care. Biomed Pharmacother. 2022; 146:112503.","DOI":"10.1016\/j.biopha.2021.112503"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Aldea M, Andre F, Marabelle A, Dogan S, Barlesi F, Soria J-C. Overcoming resistance to tumor-targeted and immune-targeted therapies. Cancer Discov. 2021; 11:874-899.","DOI":"10.1158\/2159-8290.CD-20-1638"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. P\u00e9rez-Gonz\u00e1lez A, B\u00e9vant K, Blanpain C. Cancer cell plasticity during tumor progression, metastasis and response to therapy. Nature Cancer. 2023; 4:1063-1082.","DOI":"10.1038\/s43018-023-00595-y"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Jing X, Yang F, Shao C, Wei K, Xie M, Shen H, Shu Y. Role of hypoxia in cancer therapy by regulating the tumor microenvironment. Mol Cancer. 2019; 18:1-15.","DOI":"10.1186\/s12943-019-1089-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Suwa T, Kobayashi M, Nam J-M, Harada H. Tumor microenvironment and radioresistance. Exp Mol Med. 2021; 53:1029-1035.","DOI":"10.1038\/s12276-021-00640-9"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kirtane K, Elmariah H, Chung CH, Abate-Daga D. Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead. J Immunother Cancer. 2021; 9:e002723.","DOI":"10.1136\/jitc-2021-002723"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Tang Y, Zhou Y, Li HJ. Advances in mesenchymal stem cell exosomes: a review. Stem Cell Res Ther. 2021; 12:71.","DOI":"10.1186\/s13287-021-02138-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mei R, Wan Z, Yang C, Shen X, Wang R, Zhang H, Yang R, Li J, Song Y, Su H. Advances and clinical challenges of mesenchymal stem cell therapy. Front Immunol. 2024; 15:1421854.","DOI":"10.3389\/fimmu.2024.1421854"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Shi Y, Zhang J, Li Y, Feng C, Shao C, Shi Y, Fang J. Engineered mesenchymal stem\/stromal cells against cancer. Cell Death Dis. 2025; 16:113.","DOI":"10.1038\/s41419-025-07443-0"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lan T, Luo M, Wei X. Mesenchymal stem\/stromal cells in cancer therapy. J Hematol Oncol. 2021; 14:1-16.","DOI":"10.1186\/s13045-021-01208-w"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Zhao Y, Shen M, Wu L, Yang H, Yao Y, Yang Q, Du J, Liu L, Li Y, Bai Y. Stromal cells in the tumor microenvironment: accomplices of tumor progression? Cell Death Dis. 2023; 14:587.","DOI":"10.1038\/s41419-023-06110-6"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Li X, Fan Q, Peng X, Yang S, Wei S, Liu J, Yang L, Li H. Mesenchymal\/stromal stem cells: necessary factors in tumour progression. Cell Death Dis. 2022; 8:333.","DOI":"10.1038\/s41420-022-01107-0"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Antoon R, Overdevest N, Saleh AH, Keating A. Mesenchymal stromal cells as cancer promoters. Oncogene. 2024; 1-11.","DOI":"10.1038\/s41388-024-03183-1"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lotfy A, AboQuella NM, Wang H. Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther. 2023; 14:66.","DOI":"10.1186\/s13287-023-03287-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Luo T, von der Ohe J, Hass R. MSC-Derived Extracellular Vesicles in Tumors and Therapy. Cancers (Basel). 2021; 13.","DOI":"10.3390\/cancers13205212"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Lin Z, Wu Y, Xu Y, Li G, Li Z, Liu T. Mesenchymal stem cell-derived exosomes in cancer therapy resistance: recent advances and therapeutic potential. Mol Cancer. 2022; 21:179.","DOI":"10.1186\/s12943-022-01650-5"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Guo G, Tan Z, Liu Y, Shi F, She J. The therapeutic potential of stem cell-derived exosomes in the ulcerative colitis and colorectal cancer. Stem Cell Res Ther. 2022; 13:138.","DOI":"10.1186\/s13287-022-02811-5"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Minev T, Balbuena S, Gill JM, Marincola FM, Kesari S, Lin F. Mesenchymal stem cells-the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists. Oncotarget. 2024; 15:793-805.","DOI":"10.18632\/oncotarget.28672"},{"key":"26","unstructured":"26. Batista IA, Machado JC, Melo SA. Advances in exosomes utilization for clinical applications in cancer. Trends Cancer."},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Gemayel J, Chaker D, El Hachem G, Mhanna M, Salemeh R, Hanna C, Harb F, Ibrahim A, Chebly A, Khalil C. Mesenchymal stem cells-derived secretome and extracellular vesicles: perspective and challenges in cancer therapy and clinical applications. Clin Transl Oncol. 2023; 25:2056-2068.","DOI":"10.1007\/s12094-023-03115-7"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Muthu S, Bapat A, Jain R, Jeyaraman N, Jeyaraman M. Exosomal therapy\u2014A new frontier in regenerative medicine. Stem Cell Investig. 2021; 8:7.","DOI":"10.21037\/sci-2020-037"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Tavasolian F, Hosseini AZ, Rashidi M, Soudi S, Abdollahi E, Momtazi-Borojeni AA, Sathyapalan T, Sahebkar A. The impact of immune cell-derived exosomes on immune response initiation and immune system function. Curr Pharm Des. 2021; 27:197-205.","DOI":"10.2174\/1381612826666201207221819"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Whiteside TL, Diergaarde B, Hong C-S. Tumor-derived exosomes (TEX) and their role in immuno-oncology. Int J Mol Sci. 2021; 22:6234.","DOI":"10.3390\/ijms22126234"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Wessler S, Meisner-Kober N. On the road: extracellular vesicles in intercellular communication. Cell Commun Signal. 2025; 23:95.","DOI":"10.1186\/s12964-024-01999-8"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Panda B, Sharma Y, Gupta S, Mohanty S. Mesenchymal Stem Cell-Derived Exosomes as an Emerging Paradigm for Regenerative Therapy and Nano-Medicine: A Comprehensive Review. Life (Basel). 2021; 11.","DOI":"10.3390\/life11080784"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kalluri R, LeBleu <i>VS.<\/i> The biology, function, and biomedical applications of exosomes. Science. 2020; 367.","DOI":"10.1126\/science.aau6977"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Chaudhary N, Gomez GA, Howes MT, Lo HP, McMahon K-A, Rae JA, Schieber NL, Hill MM, Gaus K, Yap AS. Endocytic crosstalk: cavins, caveolins, and caveolae regulate clathrin-independent endocytosis. PLoS Biol. 2014; 12:e1001832.","DOI":"10.1371\/journal.pbio.1001832"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Kaksonen M, Roux A. Mechanisms of clathrin-mediated endocytosis. Nat Rev Mol Cell Biol. 2018; 19:313-326.","DOI":"10.1038\/nrm.2017.132"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Mayor S, Parton RG, Donaldson JG. Clathrin-independent pathways of endocytosis. Cold Spring Harb Perspect Biol. 2014; 6:a016758.","DOI":"10.1101\/cshperspect.a016758"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Hullin-Matsuda F, Colosetti P, Rabia M, Luquain-Costaz C, Delton I. Exosomal lipids from membrane organization to biomarkers: Focus on an endolysosomal-specific lipid. Biochimie. 2022; 203:77-92.","DOI":"10.1016\/j.biochi.2022.09.016"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Skotland T, Sandvig K, Llorente A. Lipids in exosomes: Current knowledge and the way forward. Prog Lipid Res. 2017; 66:30-41.","DOI":"10.1016\/j.plipres.2017.03.001"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Bru\u0308gger B, Simons M. Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science. 2008; 319:1244-1247.","DOI":"10.1126\/science.1153124"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Menck K, S\u00f6nmezer C, Worst TS, Schulz M, Dihazi GH, Streit F, Erdmann G, Kling S, Boutros M, Binder C. Neutral sphingomyelinases control extracellular vesicles budding from the plasma membrane. J Extracell Vesicles. 2017; 6:1378056.","DOI":"10.1080\/20013078.2017.1378056"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Pfitzner A-K, Mercier V, Jiang X, von Filseck JM, Baum B, \u0160ari\u0107 A, Roux A. An ESCRT-III polymerization sequence drives membrane deformation and fission. Cell. 2020; 182:1140-1155. e1118.","DOI":"10.1016\/j.cell.2020.07.021"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Arya SB, Collie SP, Parent CA. The ins-and-outs of exosome biogenesis, secretion, and internalization. Trends Cell Biol. 2024; 34:90-108.","DOI":"10.1016\/j.tcb.2023.06.006"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Qiu G, Zheng G, Ge M, Wang J, Huang R, Shu Q, Xu J. Functional proteins of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther. 2019; 10:359.","DOI":"10.1186\/s13287-019-1484-6"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Liu Y, Wang M, Yu Y, Li C, Zhang C. Advances in the study of exosomes derived from mesenchymal stem cells and cardiac cells for the treatment of myocardial infarction. Cell Commun Signal. 2023; 21:202.","DOI":"10.1186\/s12964-023-01227-9"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. von Lersner AK, Fernandes F, Ozawa PMM, Jackson M, Masureel M, Ho H, Lima SM, Vagner T, Sung BH, Wehbe M. Multiparametric single-vesicle flow cytometry resolves extracellular vesicle heterogeneity and reveals selective regulation of biogenesis and cargo distribution. ACS Nano. 2024; 18:10464-10484.","DOI":"10.1021\/acsnano.3c11561"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Stuffers S, Sem Wegner C, Stenmark H, Brech A. Multivesicular endosome biogenesis in the absence of ESCRTs. Traffic. 2009; 10:925-937.","DOI":"10.1111\/j.1600-0854.2009.00920.x"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Kou M, Huang L, Yang J, <i>et al<\/i>. Mesenchymal stem cell-derived extracellular vesicles for immunomodulation and regeneration: a next generation therapeutic tool? Cell Death Dis. 2022; 13:580.","DOI":"10.1038\/s41419-022-05034-x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Blanc L, Vidal M. New insights into the function of Rab GTPases in the context of exosomal secretion. Small GTPases. 2018; 9:95-106.","DOI":"10.1080\/21541248.2016.1264352"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Poteryaev D, Datta S, Ackema K, Zerial M, Spang A. Identification of the switch in early-to-late endosome transition. Cell. 2010; 141:497-508.","DOI":"10.1016\/j.cell.2010.03.011"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Vanlandingham PA, Ceresa BP. Rab7 regulates late endocytic trafficking downstream of multivesicular body biogenesis and cargo sequestration. J Biol Chem. 2009; 284:12110-12124.","DOI":"10.1074\/jbc.M809277200"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Bilodeau PS, Urbanowski JL, Winistorfer SC, Piper RC. The Vps27p\u2013Hse1p complex binds ubiquitin and mediates endosomal protein sorting. Nat Cell Biol. 2002; 4:534-539.","DOI":"10.1038\/ncb815"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Lei Z, Wang J, Zhang L, Liu CH. Ubiquitination-dependent regulation of small GTPases in membrane trafficking: from cell biology to human diseases. Front Cell Dev Biol. 2021; 9:688352.","DOI":"10.3389\/fcell.2021.688352"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Song L, Tang S, Han X, Jiang Z, Dong L, Liu C, Liang X, Dong J, Qiu C, Wang Y. KIBRA controls exosome secretion <i>via<\/i> inhibiting the proteasomal degradation of Rab27a. Nat Commun. 2019; 10:1639.","DOI":"10.1038\/s41467-019-09720-x"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Wei H, Chen Q, Lin L, Sha C, Li T, Liu Y, Yin X, Xu Y, Chen L, Gao W. Regulation of exosome production and cargo sorting. Int J Biol Sci. 2021; 17:163.","DOI":"10.7150\/ijbs.53671"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Ostrowski M, Carmo NB, Krumeich S, Fanget I, Raposo G, Savina A, Moita CF, Schauer K, Hume AN, Freitas RP. Rab27a and Rab27b control different steps of the exosome secretion pathway. Nature Cell Biol. 2010; 12:19-30.","DOI":"10.1038\/ncb2000"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Wei D, Zhan W, Gao Y, Huang L, Gong R, Wang W, Zhang R, Wu Y, Gao S, Kang T. RAB31 marks and controls an ESCRT-independent exosome pathway. Cell Res. 2021; 31:157-177.","DOI":"10.1038\/s41422-020-00409-1"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Kenific CM, Zhang H, Lyden D. An exosome pathway without an ESCRT. Cell Res. 2021; 31:105-106.","DOI":"10.1038\/s41422-020-00418-0"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Hsu C, Morohashi Y, Yoshimura S-i, Manrique-Hoyos N, Jung S, Lauterbach MA, Bakhti M, Gr\u00f8nborg M, M\u00f6bius W, Rhee J. Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A\u2013C. J Cell Biol. 2010; 189:223-232.","DOI":"10.1083\/jcb.200911018"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Gorji\u2010bahri G, Moghimi HR, Hashemi A. RAB5A is associated with genes involved in exosome secretion: Integration of bioinformatics analysis and experimental validation. J Cell Biochem. 2021; 122:425-441.","DOI":"10.1002\/jcb.29871"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Hinger SA, Abner JJ, Franklin JL, Jeppesen DK, Coffey RJ, Patton JG. Rab13 regulates sEV secretion in mutant KRAS colorectal cancer cells. Sci Rep. 2020; 10:15804.","DOI":"10.1038\/s41598-020-72503-8"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, D&apos;Souza-Schorey C. ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol. 2009; 19:1875-1885.","DOI":"10.1016\/j.cub.2009.09.059"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Murray DH, Jahnel M, Lauer J, Avellaneda MJ, Brouilly N, Cezanne A, Morales-Navarrete H, Perini ED, Ferguson C, Lupas AN. An endosomal tether undergoes an entropic collapse to bring vesicles together. Nature. 2016; 537:107-111.","DOI":"10.1038\/nature19326"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, Ivarsson Y, Depoortere F, Coomans C, Vermeiren E. Syndecan\u2013syntenin\u2013ALIX regulates the biogenesis of exosomes. Nat Cell Biol. 2012; 14:677-685.","DOI":"10.1038\/ncb2502"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Ja\u00e9 N, McEwan DG, Manavski Y, Boon RA, Dimmeler S. Rab7a and Rab27b control secretion of endothelial microRNA through extracellular vesicles. FEBS letters. 2015; 589:3182-3188.","DOI":"10.1016\/j.febslet.2015.08.040"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Mizuno K, Tolmachova T, Ushakov DS, Romao M, \u00c5brink M, Ferenczi MA, Raposo G, Seabra MC. Rab27b regulates mast cell granule dynamics and secretion. Traffic. 2007; 8:883-892.","DOI":"10.1111\/j.1600-0854.2007.00571.x"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Xu M-y, Ye Z-s, Song X-t, Huang R-c. Differences in the cargos and functions of exosomes derived from six cardiac cell types: a systematic review. Stem Cell Res Ther. 2019; 10:194.","DOI":"10.1186\/s13287-019-1297-7"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Burtenshaw D, Regan B, Owen K, Collins D, McEneaney D, Megson IL, Redmond EM, Cahill PA. Exosomal Composition, Biogenesis and Profiling Using Point-of-Care Diagnostics-Implications for Cardiovascular Disease. Front Cell Dev Biol. 2022; 10:853451.","DOI":"10.3389\/fcell.2022.853451"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Lobb RJ, Hastie ML, Norris EL, van Amerongen R, Gorman JJ, M\u00f6ller A. Oncogenic transformation of lung cells results in distinct exosome protein profile similar to the cell of origin. Proteomics. 2017; 17:1600432.","DOI":"10.1002\/pmic.201600432"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Pardini B, Sabo AA, Birolo G, Calin GA. Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies. Cancers. 2019; 11:1170.","DOI":"10.3390\/cancers11081170"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Wen D, Peng Y, Liu D, Weizmann Y, Mahato RI. Mesenchymal stem cell and derived exosome as small RNA carrier and Immunomodulator to improve islet transplantation. J Control Release. 2016; 238:166-175.","DOI":"10.1016\/j.jconrel.2016.07.044"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Llorente A, Skotland T, Sylv\u00e4nne T, Kauhanen D, R\u00f3g T, Or\u0142owski A, Vattulainen I, Ekroos K, Sandvig K. Molecular lipidomics of exosomes released by PC-3 prostate cancer cells. Biochim Biophys Acta. 2013; 1831:1302-1309.","DOI":"10.1016\/j.bbalip.2013.04.011"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. Eden ER, Sanchez-Heras E, Tsapara A, Sobota A, Levine TP, Futter CE. Annexin A1 tethers membrane contact sites that mediate ER to endosome cholesterol transport. Dev Cell. 2016; 37:473-483.","DOI":"10.1016\/j.devcel.2016.05.005"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. Wilhelm LP, Wendling C, V\u00e9die B, Kobayashi T, Chenard MP, Tomasetto C, Drin G, Alpy F. STARD 3 mediates endoplasmic reticulum\u2010to\u2010endosome cholesterol transport at membrane contact sites. EMBO J. 2017; 36:1412-1433.","DOI":"10.15252\/embj.201695917"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Palmulli R, Couty M, Piontek MC, Ponnaiah M, Dingli F, Verweij FJ, Charrin S, Tantucci M, Sasidharan S, Rubinstein E. CD63 sorts cholesterol into endosomes for storage and distribution <i>via<\/i> exosomes. Nature Cell Biol. 2024; 26:1093-1109.","DOI":"10.1038\/s41556-024-01432-9"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Lu M-A, Qian Y, Ma L, Guo Q, Gao N. Molecular mechanism of the flotillin complex in membrane microdomain organization. bioRxiv. 2024; 2024.2005. 2025.595881.","DOI":"10.1101\/2024.05.25.595881"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Bodin S, Elhabashy H, Macdonald E, Winter D, Gauthier\u2010Rouvi\u00e8re C. Flotillins in membrane trafficking and physiopathology. Biol Cell. 2025; 117:e2400134.","DOI":"10.1111\/boc.202400134"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77. Abdelsalam M, Ahmed M, Osaid Z, Hamoudi R, Harati R. Insights into exosome transport through the blood\u2013brain barrier and the potential therapeutical applications in brain diseases. Pharmaceuticals. 2023; 16:571.","DOI":"10.3390\/ph16040571"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Elliott RO, He M. Unlocking the power of exosomes for crossing biological barriers in drug delivery. Pharmaceutics. 2021; 13:122.","DOI":"10.3390\/pharmaceutics13010122"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Guo Y, Sirkis DW, Schekman R. Protein sorting at the trans-Golgi network. Annu Rev Cell Dev Biol. 2014; 30:169-206.","DOI":"10.1146\/annurev-cellbio-100913-013012"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Raiborg C, Stenmark H. The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature. 2009; 458:445-452.","DOI":"10.1038\/nature07961"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Huebner AR, Cheng L, Somparn P, Knepper MA, Fenton RA, Pisitkun T. Deubiquitylation of protein cargo is not an essential step in exosome formation. Mol Cell Proteomics. 2016; 15:1556-1571.","DOI":"10.1074\/mcp.M115.054965"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Huang S, Wang Y. Golgi structure formation, function, and post-translational modifications in mammalian cells. F1000Research. 2017; 6:F1000 Faculty Rev-2050.","DOI":"10.12688\/f1000research.11900.1"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Szab\u00f3-Taylor K, Ryan B, Osteikoetxea X, Szab\u00f3 TG, S\u00f3dar B, Holub M, N\u00e9meth A, P\u00e1l\u00f3czi K, P\u00e1llinger \u00c9, Winyard P. Oxidative and other posttranslational modifications in extracellular vesicle biology. In: Seminars in Cell &amp; Developmental Biology (Elsevier, 2015; pp. 8-16.","DOI":"10.1016\/j.semcdb.2015.02.012"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84. Gomez-Navarro N, Miller E. Protein sorting at the ER\u2013Golgi interface. J Cell Biol. 2016; 215:769-778.","DOI":"10.1083\/jcb.201610031"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85. Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, Yu Z, Yang J, Wang B, Sun H. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018; 560:382-386.","DOI":"10.1038\/s41586-018-0392-8"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86. Colombo M, Moita C, Van Niel G, Kowal J, Vigneron J, Benaroch P, Manel N, Moita LF, Th\u00e9ry C, Raposo G. Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles. J Cell Sci. 2013; 126:5553-5565.","DOI":"10.1242\/jcs.128868"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87. Coonrod EM, Stevens TH. The yeast vps class E mutants: the beginning of the molecular genetic analysis of multivesicular body biogenesis. Mol Biol Cell. 2010; 21:4057-4060.","DOI":"10.1091\/mbc.e09-07-0603"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88. Rieu S, G\u00e9minard C, Rabesandratana H, Sainte\u2010Marie J, Vidal M. Exosomes released during reticulocyte maturation bind to fibronectin <i>via<\/i> integrin \u03b14\u03b21. Eur J Biochem. 2000; 267:583-590.","DOI":"10.1046\/j.1432-1327.2000.01036.x"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89. Nager AR, Goldstein JS, Herranz-P\u00e9rez V, Portran D, Ye F, Garcia-Verdugo JM, Nachury MV. An actin network dispatches ciliary GPCRs into extracellular vesicles to modulate signaling. Cell. 2017; 168:252-263. e214.","DOI":"10.1016\/j.cell.2016.11.036"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90. Ferreira A, Castanheira P, Escrevente C, Barral DC, Barona T. Membrane trafficking alterations in breast cancer progression. Front Cell Dev Biol. 2024; 12:1350097.","DOI":"10.3389\/fcell.2024.1350097"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91. Ferreira JV, da Rosa Soares A, Ramalho J, M\u00e1ximo Carvalho C, Cardoso MH, Pintado P, Carvalho AS, Beck HC, Matthiesen R, Zuzarte M. LAMP2A regulates the loading of proteins into exosomes. Sci Adv. 2022; 8:eabm1140.","DOI":"10.1126\/sciadv.abm1140"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92. Gauthier-Rouvi\u00e8re C, Bodin S, Comunale F, Planchon D. Flotillin membrane domains in cancer. Cancer Metastasis Rev. 2020; 39:361-374.","DOI":"10.1007\/s10555-020-09873-y"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93. Ferreira JV, Fofo H, Bejarano E, Bento CF, Ramalho JS, Girao H, Pereira P. STUB1\/CHIP is required for HIF1A degradation by chaperone-mediated autophagy. Autophagy. 2013; 9:1349-1366.","DOI":"10.4161\/auto.25190"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94. Cimmino F, Avitabile M, Lasorsa VA, Montella A, Pezone L, Cantalupo S, Visconte F, Corrias MV, Iolascon A, Capasso M. HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia. BMC Med Genet. 2019; 20:1-15.","DOI":"10.1186\/s12881-019-0767-1"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95. Shen S, Zhang P, Lovchik MA, Li Y, Tang L, Chen Z, Zeng R, Ma D, Yuan J, Yu Q. Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy. J Cell Biol. 2009; 185:629-639.","DOI":"10.1083\/jcb.200810183"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96. Andreu Z, Y\u00e1\u00f1ez-M\u00f3 M. Tetraspanins in extracellular vesicle formation and function. Front Immunol. 2014; 5:442.","DOI":"10.3389\/fimmu.2014.00442"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97. Arya SB, Chen S, Jordan-Javed F, Parent CA. Ceramide-rich microdomains facilitate nuclear envelope budding for non-conventional exosome formation. Nat Cell Biol. 2022; 24:1019-1028.","DOI":"10.1038\/s41556-022-00934-8"},{"key":"98","doi-asserted-by":"crossref","unstructured":"98. Todkar K, Chikhi L, Desjardins V, El-Mortada F, P\u00e9pin G, Germain M. Selective packaging of mitochondrial proteins into extracellular vesicles prevents the release of mitochondrial DAMPs. Nat Commun. 2021; 12:1971.","DOI":"10.1038\/s41467-021-21984-w"},{"key":"99","doi-asserted-by":"crossref","unstructured":"99. Duke LC, Cone AS, Sun L, Dittmer DP, Meckes DG, Tomko RJ. Tetraspanin CD9 alters cellular trafficking and endocytosis of tetraspanin CD63, affecting CD63 packaging into small extracellular vesicles. J Biol Chem. 2025; 301:108255.","DOI":"10.1016\/j.jbc.2025.108255"},{"key":"100","doi-asserted-by":"crossref","unstructured":"100. van Niel G, Charrin S, Simoes S, Romao M, Rochin L, Saftig P, Marks MS, Rubinstein E, Raposo G. The tetraspanin CD63 regulates ESCRT-independent and -dependent endosomal sorting during melanogenesis. Dev Cell. 2011; 21:708-721.","DOI":"10.1016\/j.devcel.2011.08.019"},{"key":"101","doi-asserted-by":"crossref","unstructured":"101. Nkosi D, Sun L, Duke LC, Patel N, Surapaneni SK, Singh M, Meckes Jr DG. Epstein-Barr virus LMP1 promotes syntenin-1-and Hrs-induced extracellular vesicle formation for its own secretion to increase cell proliferation and migration. MBio. 2020; 11:10.1128\/mbio. 00589-00520.","DOI":"10.1128\/mBio.00589-20"},{"key":"102","doi-asserted-by":"crossref","unstructured":"102. Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, Zheng Y, Hoshino A, Brazier H, Xiang J. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014; 24:766-769.","DOI":"10.1038\/cr.2014.44"},{"key":"103","doi-asserted-by":"crossref","unstructured":"103. Cai J, Wu G, Jose PA, Zeng C. Functional transferred DNA within extracellular vesicles. Exp Cell Res. 2016; 349:179-183.","DOI":"10.1016\/j.yexcr.2016.10.012"},{"key":"104","doi-asserted-by":"crossref","unstructured":"104. Lee YJ, Shin KJ, Chae YC. Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer. Exp Mol Med. 2024; 56:877-889.","DOI":"10.1038\/s12276-024-01209-y"},{"key":"105","doi-asserted-by":"crossref","unstructured":"105. Kim KM, Abdelmohsen K, Mustapic M, Kapogiannis D, Gorospe M. RNA in extracellular vesicles. Wiley Interdiscip Rev RNA. 2017; 8:e1413.","DOI":"10.1002\/wrna.1413"},{"key":"106","doi-asserted-by":"crossref","unstructured":"106. Sork H, Corso G, Krjutskov K, Johansson HJ, Nordin JZ, Wiklander OP, Lee YXF, Westholm JO, Lehti\u00f6 J, Wood MJ. Heterogeneity and interplay of the extracellular vesicle small RNA transcriptome and proteome. Sci Rep. 2018; 8:10813.","DOI":"10.1038\/s41598-018-28485-9"},{"key":"107","doi-asserted-by":"crossref","unstructured":"107. Garcia-Martin R, Wang G, Brand\u00e3o BB, Zanotto TM, Shah S, Kumar Patel S, Schilling B, Kahn CR. MicroRNA sequence codes for small extracellular vesicle release and cellular retention. Nature. 2022; 601:446-451.","DOI":"10.1038\/s41586-021-04234-3"},{"key":"108","doi-asserted-by":"crossref","unstructured":"108. Bolukbasi MF, Mizrak A, Ozdener GB, Madlener S, Str\u00f6bel T, Erkan EP, Fan J-B, Breakefield XO, Saydam O. miR-1289 and &quot;Zipcode&quot;-like sequence enrich mRNAs in microvesicles. Mol Ther Nucleic Acids. 2012; 1.","DOI":"10.1038\/mtna.2011.2"},{"key":"109","doi-asserted-by":"crossref","unstructured":"109. Batagov AO, Kurochkin IV. Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3\u2032-untranslated regions. Biol Direct. 2013; 8:1-8.","DOI":"10.1186\/1745-6150-8-12"},{"key":"110","doi-asserted-by":"crossref","unstructured":"110. Zheng Z, Chen M, Xing P, Yan X, Xie B. Increased expression of exosomal AGAP2-AS1 (AGAP2 antisense RNA 1) in breast cancer cells inhibits trastuzumab-induced cell cytotoxicity. Med Sci Monit. 2019; 25:2211.","DOI":"10.12659\/MSM.915419"},{"key":"111","doi-asserted-by":"crossref","unstructured":"111. Janas T, Janas MM, Sapo\u0144 K, Janas T. Mechanisms of RNA loading into exosomes. FEBS letters. 2015; 589:1391-1398.","DOI":"10.1016\/j.febslet.2015.04.036"},{"key":"112","doi-asserted-by":"crossref","unstructured":"112. Fabbiano F, Corsi J, Gurrieri E, Trevisan C, Notarangelo M, D&apos;Agostino VG. RNA packaging into extracellular vesicles: An orchestra of RNA\u2010binding proteins? J Extracell Vesicles. 2020; 10:e12043.","DOI":"10.1002\/jev2.12043"},{"key":"113","doi-asserted-by":"crossref","unstructured":"113. Chen C, Luo Y, He W, Zhao Y, Kong Y, Liu H, Zhong G, Li Y, Li J, Huang J. Exosomal long noncoding RNA LNMAT2 promotes lymphatic metastasis in bladder cancer. J Clin Invest. 2020; 130:404-421.","DOI":"10.1172\/JCI130892"},{"key":"114","doi-asserted-by":"crossref","unstructured":"114. Lei Y, Guo W, Chen B, Chen L, Gong J, Li W. Tumor\u2011released lncRNA H19 promotes gefitinib resistance <i>via<\/i> packaging into exosomes in non\u2011small cell lung cancer. Oncol Rep. 2018; 40:3438-3446.","DOI":"10.3892\/or.2018.6762"},{"key":"115","doi-asserted-by":"crossref","unstructured":"115. Qu L, Ding J, Chen C, Wu Z-J, Liu B, Gao Y, Chen W, Liu F, Sun W, Li X-F. Exosome-transmitted lncARSR promotes sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell. 2016; 29:653-668.","DOI":"10.1016\/j.ccell.2016.03.004"},{"key":"116","doi-asserted-by":"crossref","unstructured":"116. McKenzie AJ, Hoshino D, Hong NH, Cha DJ, Franklin JL, Coffey RJ, Patton JG, Weaver AM. KRAS-MEK signaling controls Ago2 sorting into exosomes. Cell Rep. 2016; 15:978-987.","DOI":"10.1016\/j.celrep.2016.03.085"},{"key":"117","doi-asserted-by":"crossref","unstructured":"117. Spada SJ, Rose KM, Sette P, O&apos;Connor SK, Dussupt V, Siddartha Yerramilli V, Nagashima K, Sjoelund VH, Cruz P, Kabat J. Human ESCRT-I and ALIX function as scaffolding helical filaments <i>in vivo<\/i>. bioRxiv. 2024; 2024.2005. 2001.592080.","DOI":"10.1101\/2024.05.01.592080"},{"key":"118","doi-asserted-by":"crossref","unstructured":"118. Iavello A, Frech VS, Gai C, Deregibus MC, Quesenberry PJ, Camussi G. Role of Alix in miRNA packaging during extracellular vesicle biogenesis. Int J Mol Med. 2016; 37:958-966.","DOI":"10.3892\/ijmm.2016.2488"},{"key":"119","doi-asserted-by":"crossref","unstructured":"119. Heusermann W, Hean J, Trojer D, Steib E, von Bueren S, Graff-Meyer A, Genoud C, Martin K, Pizzato N, Voshol J. Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER. J Cell Biol. 2016; 213:173.","DOI":"10.1083\/jcb.201506084"},{"key":"120","doi-asserted-by":"crossref","unstructured":"120. Feng D, Zhao WL, Ye YY, Bai XC, Liu RQ, Chang LF, Zhou Q, Sui SF. Cellular internalization of exosomes occurs through phagocytosis. Traffic. 2010; 11:675-687.","DOI":"10.1111\/j.1600-0854.2010.01041.x"},{"key":"121","doi-asserted-by":"crossref","unstructured":"121. Rana S, Yue S, Stadel D, Z\u00f6ller M. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol. 2012; 44:1574-1584.","DOI":"10.1016\/j.biocel.2012.06.018"},{"key":"122","doi-asserted-by":"crossref","unstructured":"122. Tkach M, Kowal J, Zucchetti AE, Enserink L, Jouve M, Lankar D, Saitakis M, Martin\u2010Jaular L, Th\u00e9ry C. Qualitative differences in T\u2010cell activation by dendritic cell\u2010derived extracellular vesicle subtypes. EMBO J. 2017; 36:3012-3028.","DOI":"10.15252\/embj.201696003"},{"key":"123","doi-asserted-by":"crossref","unstructured":"123. Gonda A, Kabagwira J, Senthil GN, Bennit HRF, Neidigh JW, Khan S, Wall NR. Exosomal survivin facilitates vesicle internalization. Oncotarget. 2018; 9:34919.","DOI":"10.18632\/oncotarget.26182"},{"key":"124","doi-asserted-by":"crossref","unstructured":"124. Montecalvo A, Larregina AT, Shufesky WJ, Beer Stolz D, Sullivan ML, Karlsson JM, Baty CJ, Gibson GA, Erdos G, Wang Z. Mechanism of transfer of functional microRNAs between mouse dendritic cells <i>via<\/i> exosomes. Blood. 2012; 119:756-766.","DOI":"10.1182\/blood-2011-02-338004"},{"key":"125","doi-asserted-by":"crossref","unstructured":"125. Gonda A, Kabagwira J, Senthil GN, Wall NR. Internalization of exosomes through receptor-mediated endocytosis. Mol Cancer Res. 2019; 17:337-347.","DOI":"10.1158\/1541-7786.MCR-18-0891"},{"key":"126","doi-asserted-by":"crossref","unstructured":"126. Tian T, Zhu Y-L, Zhou Y-Y, Liang G-F, Wang Y-Y, Hu F-H, Xiao Z-D. Exosome uptake through clathrin-mediated endocytosis and macropinocytosis and mediating miR-21 delivery. J Biol Chem. 2014; 289:22258-22267.","DOI":"10.1074\/jbc.M114.588046"},{"key":"127","doi-asserted-by":"crossref","unstructured":"127. Sung BH, von Lersner A, Guerrero J, Krystofiak ES, Inman D, Pelletier R, Zijlstra A, Ponik SM, Weaver AM. A live cell reporter of exosome secretion and uptake reveals pathfinding behavior of migrating cells. Nat Commun. 2020; 11:2092.","DOI":"10.1038\/s41467-020-15747-2"},{"key":"128","doi-asserted-by":"crossref","unstructured":"128. Joshi BS, de Beer MA, Giepmans BN, Zuhorn IS. Endocytosis of extracellular vesicles and release of their cargo from endosomes. ACS Nano. 2020; 14:4444-4455.","DOI":"10.1021\/acsnano.9b10033"},{"key":"129","doi-asserted-by":"crossref","unstructured":"129. Yao Z, Qiao Y, Li X, Chen J, Ding J, Bai L, Shen F, Shi B, Liu J, Peng L. Exosomes exploit the virus entry machinery and pathway to transmit alpha interferon-induced antiviral activity. J Virol. 2018; 92:10.1128\/jvi. 01578-01518.","DOI":"10.1128\/JVI.01578-18"},{"key":"130","doi-asserted-by":"crossref","unstructured":"130. O&apos;Brien K, Ughetto S, Mahjoum S, Nair AV, Breakefield XO. Uptake, functionality, and re-release of extracellular vesicle-encapsulated cargo. Cell Rep. 2022; 39.","DOI":"10.1016\/j.celrep.2022.110651"},{"key":"131","doi-asserted-by":"crossref","unstructured":"131. Hassanzadeh A, Rahman HS, Markov A, Endjun JJ, Zekiy AO, Chartrand MS, Beheshtkhoo N, Kouhbanani MAJ, Marofi F, Nikoo M, Jarahian M. Mesenchymal stem\/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities. Stem Cell Res Ther. 2021; 12:297.","DOI":"10.1186\/s13287-021-02378-7"},{"key":"132","doi-asserted-by":"crossref","unstructured":"132. Wang J, Pei B, Yan J, Xu X, Fang A-N, Ocansey DKW, Zhang X, Qian H, Xu W, Mao F. hucMSC-Derived Exosomes Alleviate the Deterioration of Colitis <i>via<\/i> the miR-146a\/SUMO1 Axis. Mol Pharm. 2022; 19:484-493.","DOI":"10.1021\/acs.molpharmaceut.1c00450"},{"key":"133","doi-asserted-by":"crossref","unstructured":"133. Guo Q, Yan J, Song T, Zhong C, Kuang J, Mo Y, Tan J, Li D, Sui Z, Cai K, Zhang J. microRNA-130b-3p Contained in MSC-Derived EVs Promotes Lung Cancer Progression by Regulating the FOXO3\/NFE2L2\/TXNRD1 Axis. Mol Ther Oncolytics. 2021; 20:132-146.","DOI":"10.1016\/j.omto.2020.09.005"},{"key":"134","doi-asserted-by":"crossref","unstructured":"134. Wu J, Qu Z, Fei ZW, Wu JH, Jiang CP. Role of stem cell-derived exosomes in cancer. Oncol Lett. 2017; 13:2855-2866.","DOI":"10.3892\/ol.2017.5824"},{"key":"135","doi-asserted-by":"crossref","unstructured":"135. Moeinzadeh L, Razeghian-Jahromi I, Zarei-Behjani Z, Bagheri Z, Razmkhah M. Composition, Biogenesis, and Role of Exosomes in Tumor Development. Stem Cells Int. 2022; 2022:8392509.","DOI":"10.1155\/2022\/8392509"},{"key":"136","doi-asserted-by":"crossref","unstructured":"136. Yuan Y, Tan S, Wang H, Zhu J, Li J, Zhang P, Wang M, Zhang F. Mesenchymal Stem Cell-Derived Exosomal miRNA-222-3p Increases Th1\/Th2 Ratio and Promotes Apoptosis of Acute Myeloid Leukemia Cells. Anal Cell Pathol (Amst). 2023; 2023:4024887.","DOI":"10.1155\/2023\/4024887"},{"key":"137","doi-asserted-by":"crossref","unstructured":"137. Takahara K, Ii M, Inamoto T, <i>et al<\/i>. microRNA-145 Mediates the Inhibitory Effect of Adipose Tissue-Derived Stromal Cells on Prostate Cancer. Stem Cells Dev. 2016; 25:1290-1298.","DOI":"10.1089\/scd.2016.0093"},{"key":"138","doi-asserted-by":"crossref","unstructured":"138. Jiang J, Li J, Zhou X, Zhao X, Huang B, Qin Y. Exosomes Regulate the Epithelial-Mesenchymal Transition in Cancer. Front Oncol. 2022; 12:864980.","DOI":"10.3389\/fonc.2022.864980"},{"key":"139","doi-asserted-by":"crossref","unstructured":"139. Zhou X, Li T, Chen Y, Zhang N, Wang P, Liang Y, Long M, Liu H, Mao J, Liu Q, Sun X, Chen H. Mesenchymal stem cell\u2011derived extracellular vesicles promote the <i>in vitro<\/i> proliferation and migration of breast cancer cells through the activation of the ERK pathway. Int J Oncol. 2019; 54:1843-1852.","DOI":"10.3892\/ijo.2019.4747"},{"key":"140","doi-asserted-by":"crossref","unstructured":"140. Zhu W, Huang L, Li Y, Zhang X, Gu J, Yan Y, Xu X, Wang M, Qian H, Xu W. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth <i>in vivo<\/i>. Cancer Lett. 2012; 315:28-37.","DOI":"10.1016\/j.canlet.2011.10.002"},{"key":"141","doi-asserted-by":"crossref","unstructured":"141. Gong M, Yu B, Wang J, Wang Y, Liu M, Paul C, Millard RW, Xiao DS, Ashraf M, Xu M. Mesenchymal stem cells release exosomes that transfer miRNAs to endothelial cells and promote angiogenesis. Oncotarget. 2017; 8:45200-45212.","DOI":"10.18632\/oncotarget.16778"},{"key":"142","doi-asserted-by":"crossref","unstructured":"142. Hade MD, Suire CN, Suo Z. Significant Enhancement of Fibroblast Migration, Invasion, and Proliferation by Exosomes Loaded with Human Fibroblast Growth Factor 1. ACS Appl Mater Interfaces. 2024; 16:1969-1984.","DOI":"10.1021\/acsami.3c10350"},{"key":"143","doi-asserted-by":"crossref","unstructured":"143. Lee JK, Park SR, Jung BK, Jeon YK, Lee YS, Kim MK, Kim YG, Jang JY, Kim CW. Exosomes derived from mesenchymal stem cells suppress angiogenesis by down-regulating VEGF expression in breast cancer cells. PLoS One. 2013; 8:e84256.","DOI":"10.1371\/journal.pone.0084256"},{"key":"144","doi-asserted-by":"crossref","unstructured":"144. Pakravan K, Babashah S, Sadeghizadeh M, Mowla SJ, Mossahebi-Mohammadi M, Ataei F, Dana N, Javan M. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses <i>in vitro<\/i> angiogenesis through modulating the mTOR\/HIF-1\u03b1\/VEGF signaling axis in breast cancer cells. Cell Oncol (Dordr). 2017; 40:457-470.","DOI":"10.1007\/s13402-017-0335-7"},{"key":"145","doi-asserted-by":"crossref","unstructured":"145. Essola JM, Zhang M, Yang H, Li F, Xia B, Mavoungou JF, Hussain A, Huang Y. Exosome regulation of immune response mechanism: Pros and cons in immunotherapy. Bioact Mater. 2024; 32:124-146.","DOI":"10.1016\/j.bioactmat.2023.09.018"},{"key":"146","doi-asserted-by":"crossref","unstructured":"146. He JG, Xie QL, Li BB, Zhou L, Yan D. Exosomes Derived from IDO1-Overexpressing Rat Bone Marrow Mesenchymal Stem Cells Promote Immunotolerance of Cardiac Allografts. Cell Transplant. 2018; 27:1657-1683.","DOI":"10.1177\/0963689718805375"},{"key":"147","doi-asserted-by":"crossref","unstructured":"147. Shen Z, Huang W, Liu J, Tian J, Wang S, Rui K. Effects of Mesenchymal Stem Cell-Derived Exosomes on Autoimmune Diseases. Front Immunol. 2021; 12:749192.","DOI":"10.3389\/fimmu.2021.749192"},{"key":"148","doi-asserted-by":"crossref","unstructured":"148. Blazquez R, Sanchez-Margallo FM, de la Rosa O, Dalemans W, Alvarez V, Tarazona R, Casado JG. Immunomodulatory Potential of Human Adipose Mesenchymal Stem Cells Derived Exosomes on <i>in vitro<\/i> Stimulated T Cells. Front Immunol. 2014; 5:556.","DOI":"10.3389\/fimmu.2014.00556"},{"key":"149","doi-asserted-by":"crossref","unstructured":"149. Mongui\u00f3-Tortajada M, Roura S, G\u00e1lvez-Mont\u00f3n C, Franquesa M, Bayes-Genis A, Borr\u00e0s FE. Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes <i>In Vitro<\/i> and in a Swine Model of Myocardial Infarction <i>In Vivo<\/i>. Front Immunol. 2017; 8:1577.","DOI":"10.3389\/fimmu.2017.01577"},{"key":"150","doi-asserted-by":"crossref","unstructured":"150. Wandrey M, Jablonska J, Stauber RH, G\u00fcl D. Exosomes in Cancer Progression and Therapy Resistance: Molecular Insights and Therapeutic Opportunities. Life (Basel). 2023; 13.","DOI":"10.3390\/life13102033"},{"key":"151","doi-asserted-by":"crossref","unstructured":"151. Ji R, Zhang B, Zhang X, Xue J, Yuan X, Yan Y, Wang M, Zhu W, Qian H, Xu W. Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer. Cell Cycle. 2015; 14:2473-2483.","DOI":"10.1080\/15384101.2015.1005530"},{"key":"152","doi-asserted-by":"crossref","unstructured":"152. Phan TG, Croucher PI. The dormant cancer cell life cycle. Nat Rev Cancer. 2020; 20:398-411.","DOI":"10.1038\/s41568-020-0263-0"},{"key":"153","doi-asserted-by":"crossref","unstructured":"153. Jia Z, Zhu H, Sun H, Hua Y, Zhang G, Jiang J, Wang X. Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt\/\u03b2-Catenin Signaling. Cancer Manag Res. 2020; 12:8733-8744.","DOI":"10.2147\/CMAR.S270200"},{"key":"154","doi-asserted-by":"crossref","unstructured":"154. Qiu L, Wang J, Chen M, Chen F, Tu W. Exosomal microRNA\u2011146a derived from mesenchymal stem cells increases the sensitivity of ovarian cancer cells to docetaxel and taxane <i>via<\/i> a LAMC2\u2011mediated PI3K\/Akt axis. Int J Mol Med. 2020; 46:609-620.","DOI":"10.3892\/ijmm.2020.4634"},{"key":"155","doi-asserted-by":"crossref","unstructured":"155. Xu Y, Lai Y, Cao L, Li Y, Chen G, Chen L, Weng H, Chen T, Wang L, Ye Y. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-451a represses epithelial-mesenchymal transition of hepatocellular carcinoma cells by inhibiting ADAM10. RNA Biol. 2021; 18:1408-1423.","DOI":"10.1080\/15476286.2020.1851540"},{"key":"156","doi-asserted-by":"crossref","unstructured":"156. Garc\u00eda-Foncillas J, Sunakawa Y, Aderka D, Wainberg Z, Ronga P, Witzler P, Stintzing S. Distinguishing Features of Cetuximab and Panitumumab in Colorectal Cancer and Other Solid Tumors. Front Oncol. 2019; 9:849.","DOI":"10.3389\/fonc.2019.00849"},{"key":"157","doi-asserted-by":"crossref","unstructured":"157. Saini KS, Azim HA, Metzger-Filho O, Loi S, Sotiriou C, de Azambuja E, Piccart M. Beyond trastuzumab: New treatment options for HER2-positive breast cancer. The Breast. 2011; 20:S20-S27.","DOI":"10.1016\/S0960-9776(11)70289-2"},{"key":"158","doi-asserted-by":"crossref","unstructured":"158. Viola S, Traer E, Huan J, Hornick NI, Tyner JW, Agarwal A, Loriaux M, Johnstone B, Kurre P. Alterations in acute myeloid leukaemia bone marrow stromal cell exosome content coincide with gains in tyrosine kinase inhibitor resistance. Br J Haematol. 2016; 172:983-986.","DOI":"10.1111\/bjh.13551"},{"key":"159","doi-asserted-by":"crossref","unstructured":"159. Liu Y, Song B, Wei Y, Chen F, Chi Y, Fan H, Liu N, Li Z, Han Z, Ma F. Exosomes from mesenchymal stromal cells enhance imatinib-induced apoptosis in human leukemia cells <i>via<\/i> activation of caspase signaling pathway. Cytotherapy. 2018; 20:181-188.","DOI":"10.1016\/j.jcyt.2017.11.006"},{"key":"160","doi-asserted-by":"crossref","unstructured":"160. Lee YT, Tan YJ, Oon CE. Molecular targeted therapy: Treating cancer with specificity. Eur J Pharmacol. 2018; 834:188-196.","DOI":"10.1016\/j.ejphar.2018.07.034"},{"key":"161","doi-asserted-by":"crossref","unstructured":"161. Said SS, Ibrahim WN. Cancer Resistance t o Immunotherapy: Comprehensive Insights with Future Perspectives. Pharmaceutics. 2023; 15.","DOI":"10.3390\/pharmaceutics15041143"},{"key":"162","doi-asserted-by":"crossref","unstructured":"162. Wang M, Zhang B. The Immunomodulation Potential of Exosomes in Tumor Microenvironment. J Immunol Res. 2021; 2021:3710372.","DOI":"10.1155\/2021\/3710372"},{"key":"163","doi-asserted-by":"crossref","unstructured":"163. Biswas S, Mandal G, Roy Chowdhury S, Purohit S, Payne KK, Anadon C, Gupta A, Swanson P, Yu X, Conejo-Garcia JR, Bhattacharyya A. Exosomes Produced by Mesenchymal Stem Cells Drive Differentiation of Myeloid Cells into Immunosuppressive M2-Polarized Macrophages in Breast Cancer. J Immunol. 2019; 203:3447-3460.","DOI":"10.4049\/jimmunol.1900692"},{"key":"164","doi-asserted-by":"crossref","unstructured":"164. Moradi-Chaleshtori M, Bandehpour M, Heidari N, Mohammadi-Yeganeh S, Mahmoud Hashemi S. Exosome-mediated miR-33 transfer induces M1 polarization in mouse macrophages and exerts antitumor effect in 4T1 breast cancer cell line. Int Immunopharmacol. 2021; 90:107198.","DOI":"10.1016\/j.intimp.2020.107198"},{"key":"165","doi-asserted-by":"crossref","unstructured":"165. Cordonnier M, Chanteloup G, Isambert N, Seigneuric R, Fumoleau P, Garrido C, Gobbo J. Exosomes in cancer theranostic: Diamonds in the rough. Cell Adh Migr. 2017; 11:151-163.","DOI":"10.1080\/19336918.2016.1250999"},{"key":"166","doi-asserted-by":"crossref","unstructured":"166. Dalmizrak A, Dalmizrak O. Mesenchymal stem cell-derived exosomes as new tools for delivery of miRNAs in the treatment of cancer. Front Bioeng Biotechnol. 2022; 10:956563.","DOI":"10.3389\/fbioe.2022.956563"},{"key":"167","doi-asserted-by":"crossref","unstructured":"167. Abbasi R, Mesgin RM, Nazari-Khanamiri F, Abdyazdani N, Imani Z, Talatapeh SP, Nourmohammadi A, Nejati V, Rezaie J. Mesenchymal stem cells-derived exosomes: novel carriers for nanoparticle to combat cancer. Eur J Med Res. 2023; 28:579.","DOI":"10.1186\/s40001-023-01556-y"},{"key":"168","doi-asserted-by":"crossref","unstructured":"168. Zhou Y, Dong Y, Zhang A, Wu J, Sun Q. The role of mesenchymal stem cells derived exosomes as a novel nanobiotechnology target in the diagnosis and treatment of cancer. Front Bioeng Biotechnol. 2023; 11:1214190.","DOI":"10.3389\/fbioe.2023.1214190"},{"key":"169","doi-asserted-by":"crossref","unstructured":"169. Sen S, Xavier J, Kumar N, Ahmad MZ, Ranjan OP. Exosomes as natural nanocarrier-based drug delivery system: recent insights and future perspectives. 3 Biotech. 2023; 13:101.","DOI":"10.1007\/s13205-023-03521-2"},{"key":"170","doi-asserted-by":"crossref","unstructured":"170. Pakravan K, Babashah S, Sadeghizadeh M, Mowla SJ, Mossahebi-Mohammadi M, Ataei F, Dana N, Javan M. MicroRNA-100 shuttled by mesenchymal stem cell-derived exosomes suppresses <i>in vitro<\/i> angiogenesis through modulating the mTOR\/HIF-1\u03b1\/VEGF signaling axis in breast cancer cells. Cellular Oncology. 2017; 40:457-470.","DOI":"10.1007\/s13402-017-0335-7"},{"key":"171","doi-asserted-by":"crossref","unstructured":"171. Al-Awsi GRL, Alsaikhan F, Margiana R, Ahmad I, Patra I, Najm MAA, Yasin G, Rasulova I, Hammid AT, Kzar HH, Al-Gazally ME, Siahmansouri H. Shining the light on mesenchymal stem cell-derived exosomes in breast cancer. Stem Cell Res Ther. 2023; 14:21.","DOI":"10.1186\/s13287-023-03245-3"},{"key":"172","doi-asserted-by":"crossref","unstructured":"172. Sachdeva M, Mo YY. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res. 2010; 70:378-387.","DOI":"10.1158\/0008-5472.CAN-09-2021"},{"key":"173","doi-asserted-by":"crossref","unstructured":"173. Du L, Tao X, Shen X. Human umbilical cord mesenchymal stem cell-derived exosomes inhibit migration and invasion of breast cancer cells <i>via<\/i> miR-21-5p\/ZNF367 pathway. Breast Cancer. 2021; 28:829-837.","DOI":"10.1007\/s12282-021-01218-z"},{"key":"174","doi-asserted-by":"crossref","unstructured":"174. Jiang Z, Zhang Y, Zhang Y, Jia Z, Zhang Z, Yang J. Cancer derived exosomes induce macrophages immunosuppressive polarization to promote bladder cancer progression. Cell Commun Signal. 2021; 19:93.","DOI":"10.1186\/s12964-021-00768-1"},{"key":"175","doi-asserted-by":"crossref","unstructured":"175. Wang S, Lu J, You Q, Huang H, Chen Y, Liu K. The mTOR\/AP-1\/VEGF signaling pathway regulates vascular endothelial cell growth. Oncotarget. 2016; 7:53269-53276.","DOI":"10.18632\/oncotarget.10756"},{"key":"176","doi-asserted-by":"crossref","unstructured":"176. Jia Z, Zhu H, Sun H, Hua Y, Zhang G, Jiang J, Wang X. Adipose Mesenchymal Stem Cell-Derived Exosomal microRNA-1236 Reduces Resistance of Breast Cancer Cells to Cisplatin by Suppressing SLC9A1 and the Wnt\/\u03b2-Catenin Signaling. Cancer Management and Research. 2020; Volume 12:8733-8744.","DOI":"10.2147\/CMAR.S270200"},{"key":"177","doi-asserted-by":"crossref","unstructured":"177. Zhu Q, Cao Y, Yuan J, Hu Y. Adipose-derived stem cell exosomes promote tumor characterization and immunosuppressive microenvironment in breast cancer. Cancer Immunol Immunother. 2024; 73:39.","DOI":"10.1007\/s00262-023-03584-3"},{"key":"178","doi-asserted-by":"crossref","unstructured":"178. Liang Y, Zhang D, Li L, Xin T, Zhao Y, Ma R, Du J. Exosomal microRNA-144 from bone marrow-derived mesenchymal stem cells inhibits the progression of non-small cell lung cancer by targeting CCNE1 and CCNE2. Stem Cell Res Ther. 2020; 11:87.","DOI":"10.1186\/s13287-020-1580-7"},{"key":"179","unstructured":"179. Chen J, Ding C, Yang X, Zhao J. BMSCs-Derived Exosomal MiR-126-3p Inhibits the Viability of NSCLC Cells by Targeting PTPN9. Journal of BUON : official journal of the Balkan Union of Oncology. 2021; 26:1832-1841."},{"key":"180","doi-asserted-by":"crossref","unstructured":"180. Zhang C, Cao J, Lv W, Mou H. CircRNA_100395 Carried by Exosomes From Adipose-Derived Mesenchymal Stem Cells Inhibits the Malignant Transformation of Non-Small Cell Lung Carcinoma Through the miR-141-3p-LATS2 Axis. Front Cell Dev Biol. 2021; 9:663147.","DOI":"10.3389\/fcell.2021.663147"},{"key":"181","doi-asserted-by":"crossref","unstructured":"181. Liu XN, Zhang CB, Lin H, Tang XY, Zhou R, Wen HL, Li J. microRNA-204 shuttled by mesenchymal stem cell-derived exosomes inhibits the migration and invasion of non-small-cell lung cancer cells <i>via<\/i> the KLF7\/AKT\/HIF-1\u03b1 axis. Neoplasma. 2021; 68:719-731.","DOI":"10.4149\/neo_2021_201208N1328"},{"key":"182","doi-asserted-by":"crossref","unstructured":"182. Feng Y, Guo K, Jiang J, Lin S. Mesenchymal stem cell-derived exosomes as delivery vehicles for non-coding RNAs in lung diseases. Biomed Pharmacother. 2024; 170:116008.","DOI":"10.1016\/j.biopha.2023.116008"},{"key":"183","doi-asserted-by":"crossref","unstructured":"183. Ahn SY. T h e R o l e o f MSCs i n t h e Tu m o r Microenvironment and Tumor Progression. Anticancer Res. 2020; 40:3039-3047.","DOI":"10.21873\/anticanres.14284"},{"key":"184","doi-asserted-by":"crossref","unstructured":"184. Tang J, Li X, Cheng T, Wu J. miR-21-5p\/SMAD7 axis promotes the progress of lung cancer. Thorac Cancer. 2021; 12:2307-2313.","DOI":"10.1111\/1759-7714.14060"},{"key":"185","doi-asserted-by":"crossref","unstructured":"185. Wang G, Ji X, Li P, Wang W. Human bone marrow mesenchymal stem cell-derived exosomes containing microRNA-425 promote migration, invasion and lung metastasis by down-regulating CPEB1. Regen Ther. 2022; 20:107-116.","DOI":"10.1016\/j.reth.2022.03.007"},{"key":"186","doi-asserted-by":"crossref","unstructured":"186. Guo Q, Yan J, Song T, Zhong C, Kuang J, Mo Y, Tan J, Li D, Sui Z, Cai K, Zhang J. microRNA-130b-3p contained in MSC-derived EVs promotes lung cancer progression by regulating the FOXO3\/NFE2L2\/TXNRD1 axis. Molecular Therapy - Oncolytics. 2021; 20:132-146.","DOI":"10.1016\/j.omto.2020.09.005"},{"key":"187","doi-asserted-by":"crossref","unstructured":"187. Zhang X, Sai B, Wang F, Wang L, Wang Y, Zheng L, Li G, Tang J, Xiang J. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells <i>via<\/i> STAT3-induced EMT. Mol Cancer. 2019; 18:40.","DOI":"10.1186\/s12943-019-0959-5"},{"key":"188","doi-asserted-by":"crossref","unstructured":"188. Zhao LX, Zhang K, Shen BB, Li JN. Mesenchymal stem cell-derived exosomes for gastrointestinal cancer. World J Gastrointest Oncol. 2021; 13:1981-1996.","DOI":"10.4251\/wjgo.v13.i12.1981"},{"key":"189","doi-asserted-by":"crossref","unstructured":"189. Fang Y, Liang X, Xu J, Cai X. miR-424 targets AKT3 and PSAT1 and has a tumor-suppressive role in human colorectal cancer. Cancer Manag Res. 2018; 6537-6547.","DOI":"10.2147\/CMAR.S185789"},{"key":"190","doi-asserted-by":"crossref","unstructured":"190. Zhang N, Li L, Luo J, Tan J, Hu W, Li Z, Wang X, Ye T. RETRACTED: Inhibiting microRNA-424 in bone marrow mesenchymal stem cells-derived exosomes suppresses tumor growth in colorectal cancer by upregulating TGFBR3. Arch Biochem Biophys. 2021; 709:108965.","DOI":"10.1016\/j.abb.2021.108965"},{"key":"191","doi-asserted-by":"crossref","unstructured":"191. Li H, Li F. Exosomes from BM-MSCs increase the population of CSCs <i>via<\/i> transfer of miR-142-3p. Br J Cancer. 2018; 119:744-755.","DOI":"10.1038\/s41416-018-0254-z"},{"key":"192","doi-asserted-by":"crossref","unstructured":"192. Qu M, Li J, Hong Z, Jia F, He Y, Yuan L. The role of human umbilical cord mesenchymal stem cells-derived exosomal microRNA-431-5p in survival and prognosis of colorectal cancer patients. Mutagenesis. 2022; 37:164-171.","DOI":"10.1093\/mutage\/geac007"},{"key":"193","doi-asserted-by":"crossref","unstructured":"193. Xu Y, Shen L, Li F, Yang J, Wan X, Ouyang M. microRNA\u201016\u20105p\u2010containing exosomes derived from bone marrow\u2010derived mesenchymal stem cells inhibit proliferation, migration, and invasion, while promoting apoptosis of colorectal cancer cells by downregulating ITGA2. J Cell Physiol. 2019; 234:21380-21394.","DOI":"10.1002\/jcp.28747"},{"key":"194","doi-asserted-by":"crossref","unstructured":"194. Wang Y, Lin C. Exosomes miR-22-3p Derived from Mesenchymal Stem Cells Suppress Colorectal Cancer Cell Proliferation and Invasion by Regulating RAP2B and PI3K\/AKT Pathway. J Oncol. 2021; 2021:1-10.","DOI":"10.1155\/2021\/3874478"},{"key":"195","doi-asserted-by":"crossref","unstructured":"195. Li T, Wan Y, Su Z, Li J, Han M, Zhou C. Mesenchymal stem cell-derived exosomal microRNA-3940-5p inhibits colorectal cancer metastasis by targeting integrin \u03b16. Dig Dis Sci. 2021; 66:1916-1927.","DOI":"10.1007\/s10620-020-06458-1"},{"key":"196","doi-asserted-by":"crossref","unstructured":"196. Mansourabadi AH, Aghamajidi A, Faraji F, Taghizadeh S, Mohamed Khosroshahi L, Bahramkiya M, Azimi M. Mesenchymal stem cells-derived exosomes inhibit the expression of Aquaporin-5 and EGFR in HCT-116 human colorectal carcinoma cell line. BMC Mol Cell Biol. 2022; 23:40.","DOI":"10.1186\/s12860-022-00439-0"},{"key":"197","doi-asserted-by":"crossref","unstructured":"197. Gu H, Ji R, Zhang X, Wang M, Zhu W, Qian H, Chen Y, Jiang P, Xu W. Exosomes derived from human mesenchymal stem cells promote gastric cancer cell growth and migration <i>via<\/i> the activation of the Akt pathway. Mol Med Rep. 2016; 14:3452-3458.","DOI":"10.3892\/mmr.2016.5625"},{"key":"198","doi-asserted-by":"crossref","unstructured":"198. Qi J, Zhou Y, Jiao Z, Wang X, Zhao Y, Li Y, Chen H, Yang L, Zhu H, Li Y. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth through hedgehog signaling pathway. Cell Physiol Biochem. 2017; 42:2242-2254.","DOI":"10.1159\/000479998"},{"key":"199","doi-asserted-by":"crossref","unstructured":"199. Chen B, Yu J, Wang Q, Zhao Y, Sun L, Xu C, Zhao X, Shen B, Wang M, Xu W. Human bone marrow mesenchymal stem cells promote gastric cancer growth <i>via<\/i> regulating c-Myc. Stem Cells Int. 2018; 2018:9501747.","DOI":"10.1155\/2018\/9501747"},{"key":"200","doi-asserted-by":"crossref","unstructured":"200. Zhu T, Hu Z, Wang Z, Ding H, Li R, Wang J, Wang G. microRNA-301b-3p from mesenchymal stem cells-derived extracellular vesicles inhibits TXNIP to promote multidrug resistance of gastric cancer cells. Cell Biol Toxicol. 2023; 39:1923-1937.","DOI":"10.1007\/s10565-021-09675-0"},{"key":"201","doi-asserted-by":"crossref","unstructured":"201. Akad F, Mocanu V, Peiu SN, Scripcariu V, Filip B, Timofte D, Zugun-Eloae F, Cuciureanu M, Hancianu M, Oboroceanu T. Mesenchymal stem cell-derived exosomes modulate angiogenesis in gastric cancer. Biomedicines. 2023; 11:1031.","DOI":"10.3390\/biomedicines11041031"},{"key":"202","doi-asserted-by":"crossref","unstructured":"202. Chang L, Gao H, Wang L, Wang N, Zhang S, Zhou X, Yang H. Exosomes derived from miR-1228 overexpressing bone marrow-mesenchymal stem cells promote growth of gastric cancer cells. Aging (Albany NY). 2021; 13:11808.","DOI":"10.18632\/aging.202878"},{"key":"203","doi-asserted-by":"crossref","unstructured":"203. You B, Jin C, Zhang J, Xu M, Xu W, Sun Z, Qian H. MSC\u2010derived extracellular vesicle\u2010delivered L\u2010PGDS inhibit gastric cancer progression by suppressing cancer cell stemness and STAT3 phosphorylation. Stem Cells Int. 2022; 2022:9668239.","DOI":"10.1155\/2022\/9668239"},{"key":"204","doi-asserted-by":"crossref","unstructured":"204. Sung H, Ferlay J , Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021; 71:209-249.","DOI":"10.3322\/caac.21660"},{"key":"205","doi-asserted-by":"crossref","unstructured":"205. ArefNezhad R, Rezaei\u2010Tazangi F, Roghani\u2010Shahraki H, Goleij P, Zare N, Motedayyen H, Aghazadeh E. Human umbilical cord mesenchymal stem cells: Heralding an effective treatment against esophageal cancer? Cell Biol Int. 2023; 47:714-719.","DOI":"10.1002\/cbin.11991"},{"key":"206","unstructured":"206. Liu J, Chen L, Deng H, Xu B, Li M, Zheng X, Wu C, Jiang J. Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient&apos;s survival. Int J Clin Exp Pathol. 2014; 7:6943."},{"key":"207","doi-asserted-by":"crossref","unstructured":"207. He Z, Li W, Zheng T, Liu D, Zhao S. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression. J Exp Clin Cancer Res. 2020; 39:1-18.","DOI":"10.1186\/s13046-020-01631-w"},{"key":"208","doi-asserted-by":"crossref","unstructured":"208. Zelli V, Compagnoni C, Capelli R, Corrente A, Di Vito Nolfi M, Zazzeroni F, Alesse E, Tessitore A. Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma. Front Oncol. 2022; 12:940056.","DOI":"10.3389\/fonc.2022.940056"},{"key":"209","doi-asserted-by":"crossref","unstructured":"209. Li Z, Zhou Y, Zhang L, Jia K, Wang S, Wang M, Li N, Yu Y, Cao X, Hou J. microRNA-199a-3p inhibits hepatic apoptosis and hepatocarcinogenesis by targeting PDCD4. Oncogenesis. 2020; 9:95.","DOI":"10.1038\/s41389-020-00282-y"},{"key":"210","doi-asserted-by":"crossref","unstructured":"210. Fornari F, Milazzo M, Chieco P, Negrini M, Calin GA, Grazi GL, Pollutri D, Croce CM, Bolondi L, Gramantieri L. Data from MiR-199a-3p Regulates mTOR and c-Met to Influence the Doxorubicin Sensitivity of Human Hepatocarcinoma Cells. American Association for Cancer Research (AACR), 2023.","DOI":"10.1158\/0008-5472.c.6501008.v1"},{"key":"211","doi-asserted-by":"crossref","unstructured":"211. Lou G, Song X, Yang F, Wu S, Wang J, Chen Z, Liu Y. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015; 8:122.","DOI":"10.1186\/s13045-015-0220-7"},{"key":"212","doi-asserted-by":"crossref","unstructured":"212. Singh R, Cheng S, Li J, Kumar S, Zeng Q, Zeng Q. Norcantharidin combined with 2-deoxy-d-glucose suppresses the hepatocellular carcinoma cells proliferation and migration. 3 Biotech. 2021; 11:142.","DOI":"10.1007\/s13205-021-02688-w"},{"key":"213","doi-asserted-by":"crossref","unstructured":"213. Chi J, Jiang Z, Chen X, Peng Y, Liu W, Han B, Han B. Studies on anti-hepatocarcinoma effect, pharmacokinetics and tissue distribution of carboxymethyl chitosan based norcantharidin conjugates. Carbohydr Polym. 2019; 226:115297.","DOI":"10.1016\/j.carbpol.2019.115297"},{"key":"214","doi-asserted-by":"crossref","unstructured":"214. Liang, Leyi, Zhao L, Wang Y, Wang Y. Treatment for Hepatocellular Carcinoma Is Enhanced When Norcantharidin Is Encapsulated in Exosomes Derived from Bone Marrow Mesenchymal Stem Cells. Mol Pharm. 2021; 18:1003-1013.","DOI":"10.1021\/acs.molpharmaceut.0c00976"},{"key":"215","doi-asserted-by":"crossref","unstructured":"215. Dietrich B, Siefker-Radtke AO, Srinivas S, Yu EY. Systemic Therapy for Advanced Urothelial Carcinoma: Current Standards and Treatment Considerations. American Society of Clinical Oncology Educational Book. 2018; 342-353.","DOI":"10.1200\/EDBK_201193"},{"key":"216","doi-asserted-by":"crossref","unstructured":"216. Kasi\u0144ski D, Szeliski K, Drewa T, Pokrywczy\u0144ska M. Extracellular vesicles\u2014a new player in the development of urinary bladder cancer. Ther Adv Med Oncol. 2025; 17:17588359241297529.","DOI":"10.1177\/17588359241297529"},{"key":"217","doi-asserted-by":"crossref","unstructured":"217. Saadh MJ, Alhuthali HM, Gonzales An\u00edbal O, Asenjo\u2010Alarc\u00f3n JA, Younus DG, Alhili A, Adhab ZH, Alsalmi O, Gharib AF, Pecho RDC. Mesenchymal stem cells and their extracellular vesicles in urological cancers: Prostate, bladder, and kidney. Cell Biol Int. 2024; 48:3-19.","DOI":"10.1002\/cbin.12098"},{"key":"218","doi-asserted-by":"crossref","unstructured":"218. Rezaeian A, Khatami F, Heidari Keshel S, Akbari MR, Mirzaei A, Gholami K, Mohammadi Farsani R, Aghamir SMK. The effect of mesenchymal stem cells-derived exosomes on the prostate, bladder, and renal cancer cell lines. Sci Rep. 2022; 12.","DOI":"10.1038\/s41598-022-23204-x"},{"key":"219","doi-asserted-by":"crossref","unstructured":"219. Che Y, Shi X, Shi Y, Jiang X, Ai Q, Shi Y, Gong F, Jiang W. Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3. Mol Ther Nucleic Acids. 2019; 18:232-244.","DOI":"10.1016\/j.omtn.2019.08.010"},{"key":"220","doi-asserted-by":"crossref","unstructured":"220. Cai H, Yang X, Gao Y, Xu Z, Yu B, Xu T, Li X, Xu W, Wang X, Hua L. Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer. Mol Ther Nucleic Acids. 2019; 18:787-800.","DOI":"10.1016\/j.omtn.2019.09.023"},{"key":"221","doi-asserted-by":"crossref","unstructured":"221. Zheng H, Chen C, Luo Y, Yu M, He W, An M, Gao B, Kong Y, Ya Y, Lin Y. Tumor\u2010derived exosomal BCYRN1 activates WNT5A\/VEGF\u2010C\/VEGFR3 feedforward loop to drive lymphatic metastasis of bladder cancer. Clin Transl Med. 2021; 11:e497.","DOI":"10.1002\/ctm2.497"},{"key":"222","doi-asserted-by":"crossref","unstructured":"222. Xue M, Pang H, Li X, Li H, Pan J, Chen W. Long non\u2010coding RNA urothelial cancer\u2010associated 1 promotes bladder cancer cell migration and invasion by way of the hsa\u2010miR\u2010145\u2013ZEB 1\/2\u2013FSCN 1 pathway. Cancer Sci. 2016; 107:18-27.","DOI":"10.1111\/cas.12844"},{"key":"223","doi-asserted-by":"crossref","unstructured":"223. Cai X, Qu L, Yang J, Xu J, Sun L, Wei X, Qu X, Bai T, Guo Z, Zhu Y. Exosome\u2013transmitted microRNA\u2010133b inhibited bladder cancer proliferation by upregulating dual\u2010specificity protein phosphatase 1. Cancer Med. 2020; 9:6009-6019.","DOI":"10.1002\/cam4.3263"},{"key":"224","doi-asserted-by":"crossref","unstructured":"224. Kamerkar S, LeBleu VS, Sugimoto H, Yang S, Ruivo CF, Melo SA, Lee JJ, Kalluri R. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature. 2017; 546:498-503.","DOI":"10.1038\/nature22341"},{"key":"225","doi-asserted-by":"crossref","unstructured":"225. Xu B, Liu J, Xiang X, Liu S, Zhong P, Xie F, Mou T, Lai L. Expression of miRNA-143 in Pancreatic Cancer and Its Clinical Significance. Cancer Biother Radio. 2018; 33:373-379.","DOI":"10.1089\/cbr.2018.2500"},{"key":"226","doi-asserted-by":"crossref","unstructured":"226. Wang B, Xu Y, Wei Y, Lv L, Liu N, Lin R, Wang X, Shi B. Human Mesenchymal Stem Cell-Derived Exosomal microRNA-143 Promotes Apoptosis and Suppresses Cell Growth in Pancreatic Cancer <i>via<\/i> Target Gene Regulation. Front Genet. 2021; 12:581694.","DOI":"10.3389\/fgene.2021.581694"},{"key":"227","doi-asserted-by":"crossref","unstructured":"227. Xu Y, Liu N, Wei Y, Zhou D, Lin R, Wang X, Shi B. Anticancer effects of miR-124 delivered by BM-MSC derived exosomes on cell proliferation, epithelial mesenchymal transition, and chemotherapy sensitivity of pancreatic cancer cells. Aging. 2020; 12:19660-19676.","DOI":"10.18632\/aging.103997"},{"key":"228","doi-asserted-by":"crossref","unstructured":"228. Shang S, Wang J, Chen S, Tian R, Zeng H, Wang L, Xia M, Zhu H, Zuo C. Exosomal miRNA\u20101231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer. Cancer Med. 2019; 8:7728-7740.","DOI":"10.1002\/cam4.2633"},{"key":"229","doi-asserted-by":"crossref","unstructured":"229. Ding Y, Cao F, Sun H, Wang Y, Liu S, Wu Y, Cui Q, Mei W, Li F. Exosomes derived from human umbilical cord mesenchymal stromal cells deliver exogenous miR-145-5p to inhibit pancreatic ductal adenocarcinoma progression. Cancer Lett. 2019; 442:351-361.","DOI":"10.1016\/j.canlet.2018.10.039"},{"key":"230","doi-asserted-by":"crossref","unstructured":"230. Fang X, Lan H, Jin K, Qian J. Pancreatic cancer and exosomes: role in progression, diagnosis, monitoring, and treatment. Front Oncol. 2023; 13:1149551.","DOI":"10.3389\/fonc.2023.1149551"},{"key":"231","doi-asserted-by":"crossref","unstructured":"231. Zhou Y, Zhou W, Chen X, Wang Q, Li C, Chen Q, Zhang Y, Lu Y, Ding X, Jiang C. Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer. Acta Pharmaceutica Sinica B. 2020; 10:1563-1575.","DOI":"10.1016\/j.apsb.2019.11.013"},{"key":"232","doi-asserted-by":"crossref","unstructured":"232. Zhou W, Zhou Y, Chen X, Ning T, Chen H, Guo Q, Zhang Y, Liu P, Zhang Y, Li C, Chu Y, Sun T, Jiang C. Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials. 2021; 268:120546.","DOI":"10.1016\/j.biomaterials.2020.120546"},{"key":"233","doi-asserted-by":"crossref","unstructured":"233. Ord\u00f3\u00f1ez-Rubiano EG, Rinc\u00f3n-Arias N, Espinosa S, Shelton WJ, Salazar AF, C\u00f3mbita A, Baldoncini M, Luzzi S, Pay\u00e1n-G\u00f3mez C, G\u00f3mez- Amarillo DF, Hakim F, Pati\u00f1o-G\u00f3mez JG, Parra- Medina R. The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives. Curr Res Pharmacol Drug Discov. 2024; 7:100193.","DOI":"10.1016\/j.crphar.2024.100193"},{"key":"234","doi-asserted-by":"crossref","unstructured":"234. Ghasempour E, Hesami S, Movahed E, Keshel SH, Doroudian M. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy in the brain tumors. Stem Cell Res Ther. 2022; 13:527.","DOI":"10.1186\/s13287-022-03212-4"},{"key":"235","doi-asserted-by":"crossref","unstructured":"235. Lee HK, Finniss S, Cazacu S, Bucris E, Ziv-Av A, Xiang C, Bobbitt K, Rempel SA, Hasselbach L, Mikkelsen T. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget. 2013; 4:346.","DOI":"10.18632\/oncotarget.868"},{"key":"236","doi-asserted-by":"crossref","unstructured":"236. Katakowski M, Buller B, Zheng X, Lu Y, Rogers T, Osobamiro O, Shu W, Jiang F, Chopp M. Exosomes from marrow stromal cells expressing miR-146b inhibit glioma growth. Cancer Lett. 2013; 335:201-204.","DOI":"10.1016\/j.canlet.2013.02.019"},{"key":"237","doi-asserted-by":"crossref","unstructured":"237. Xu H, Zhao G, Zhang Y, Jiang H, Wang W, Zhao D, Hong J, Yu H, Qi L. Mesenchymal stem cell-derived exosomal microRNA-133b suppresses glioma progression <i>via<\/i> Wnt\/\u03b2-catenin signaling pathway by targeting EZH2. Stem Cell Res Ther. 2019; 10:381.","DOI":"10.1186\/s13287-019-1446-z"},{"key":"238","doi-asserted-by":"crossref","unstructured":"238. Munoz JL, Bliss SA, Greco SJ, Ramkissoon SH, Ligon KL, Rameshwar P. Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell-derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity. Mol Ther Nucleic Acids. 2013; 2:e126.","DOI":"10.1038\/mtna.2013.60"},{"key":"239","doi-asserted-by":"crossref","unstructured":"239. Wang CK, Tsai TH, Lee CH. Regulation of exosomes as biologic medicines: Regulatory challenges faced in exosome development and manufacturing processes. Clin Transl Sci. 2024; 17:e13904.","DOI":"10.1111\/cts.13904"},{"key":"240","doi-asserted-by":"crossref","unstructured":"240. Heidarzadeh M, G\u00fcrsoy-\u00d6zdemir Y, Kaya M, Eslami Abriz A, Zarebkohan A, Rahbarghazi R, Sokullu E. Exosomal delivery of therapeutic modulators through the blood\u2013brain barrier; promise and pitfalls. Cell Biosci. 2021; 11:1-28.","DOI":"10.1186\/s13578-021-00650-0"},{"key":"241","doi-asserted-by":"crossref","unstructured":"241. Li Y, Wu Y, Federzoni EA, Wang X, Dharmawan A, Hu X, Wang H, Hawley RJ, Stevens S, Sykes M. CD47 cross-dressing by extracellular vesicles expressing CD47 inhibits phagocytosis without transmitting cell death signals. Elife. 2022; 11:e73677.","DOI":"10.7554\/eLife.73677"},{"key":"242","doi-asserted-by":"crossref","unstructured":"242. Kim HI, Park J, Zhu Y, Wang X, Han Y, Zhang D. Recent advances in extracellular vesicles for therapeutic cargo delivery. Exp Mol Med. 2024; 56:836-849.","DOI":"10.1038\/s12276-024-01201-6"},{"key":"243","doi-asserted-by":"crossref","unstructured":"243. Sancho-Albero M, Navascu\u00e9s N, Mendoza G, Sebasti\u00e1n V, Arruebo M, Mart\u00edn-Duque P, Santamar\u00eda J. Exosome origin determines cell targeting and the transfer of therapeutic nanoparticles towards target cells. J Nanobiotechnology. 2019; 17:1-13.","DOI":"10.1186\/s12951-018-0437-z"},{"key":"244","doi-asserted-by":"crossref","unstructured":"244. Qiao L, Hu S, Huang K, Su T, Li Z, Vandergriff A, Cores J, Dinh P-U, Allen T, Shen D. Tumor cell-derived exosomes home to their cells of origin and can be used as Trojan horses to deliver cancer drugs. Theranostics. 2020; 10:3474.","DOI":"10.7150\/thno.39434"},{"key":"245","doi-asserted-by":"crossref","unstructured":"245. Hazan-Halevy I, Rosenblum D, Weinstein S, Bairey O, Raanani P, Peer D. Cell-specific uptake of mantle cell lymphoma-derived exosomes by malignant and non-malignant B-lymphocytes. Cancer Lett. 2015; 364:59-69.","DOI":"10.1016\/j.canlet.2015.04.026"},{"key":"246","doi-asserted-by":"crossref","unstructured":"246. Zeng B, Li Y, Xia J, Xiao Y, Khan N, Jiang B, Liang Y, Duan L. Micro Trojan horses: Engineering extracellular vesicles crossing biological barriers for drug delivery. Bioeng Transl Med. 2024; 9:e10623.","DOI":"10.1002\/btm2.10623"},{"key":"247","doi-asserted-by":"crossref","unstructured":"247. Zheng Z, Li P, Shen F, Shi Y, Shao C. Mesenchymal Stem\/Stromal Cells in Cancer: from Initiation to Metastasis. Arch Med Res. 2022; 53:785-793.","DOI":"10.1016\/j.arcmed.2022.11.001"},{"key":"248","doi-asserted-by":"crossref","unstructured":"248. Zhang F, Guo J, Zhang Z, Qian Y, Wang G, Duan M, Zhao H, Yang Z, Jiang X. Mesenchymal stem cell-derived exosome: A tumor regulator and carrier for targeted tumor therapy. Cancer Lett. 2022; 526:29-40.","DOI":"10.1016\/j.canlet.2021.11.015"},{"key":"249","doi-asserted-by":"crossref","unstructured":"249. Yu S, Cao H, Shen B, Feng J. Tumor-derived exosomes in cancer progression and treatment failure. Oncotarget. 2015; 6:37151-37168.","DOI":"10.18632\/oncotarget.6022"},{"key":"250","doi-asserted-by":"crossref","unstructured":"250. To KK, Cho WC. Exosome secretion from hypoxic cancer cells reshapes the tumor microenvironment and mediates drug resistance. Cancer Drug Resistance. 2022; 5:577-594.","DOI":"10.20517\/cdr.2022.38"},{"key":"251","doi-asserted-by":"crossref","unstructured":"251. Lopatina T, Bruno S, Tetta C, Kalinina N, Porta M, Camussi G. Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun Signal. 2014; 12:1-12.","DOI":"10.1186\/1478-811X-12-26"},{"key":"252","doi-asserted-by":"crossref","unstructured":"252. Chen B, Cai T, Huang C, Zang X, Sun L, Guo S, Wang Q, Chen Z, Zhao Y, Han Z. G6PD-NF-\u03baB-HGF signal in gastric cancer-associated mesenchymal stem cells promotes the proliferation and metastasis of gastric cancer cells by upregulating the expression of HK2. Front Oncol. 2021; 11:648706.","DOI":"10.3389\/fonc.2021.648706"},{"key":"253","doi-asserted-by":"crossref","unstructured":"253. Ren W, Hou J, Yang C, Wang H, Wu S, Wu Y, Zhao X, Lu C. Extracellular vesicles secreted by hypoxia pre-challenged mesenchymal stem cells promote non-small cell lung cancer cell growth and mobility as well as macrophage M2 polarization <i>via<\/i> miR-21-5p delivery. J Exp Clin Cancer Res. 2019; 38:1-14.","DOI":"10.1186\/s13046-019-1027-0"},{"key":"254","doi-asserted-by":"crossref","unstructured":"254. Wu H, Mu X, Liu L, Wu H, Hu X, Chen L, Liu J, Mu Y, Yuan F, Liu W. Bone marrow mesenchymal stem cells-derived exosomal microRNA-193a reduces cisplatin resistance of non-small cell lung cancer cells <i>via<\/i> targeting LRRC1. Cell Death Dis. 2020; 11:801.","DOI":"10.1038\/s41419-020-02962-4"},{"key":"255","doi-asserted-by":"crossref","unstructured":"255. Lou G, Chen L, Xia C, Wang W, Qi J, Li A, Zhao L, Chen Z, Zheng M, Liu Y. MiR-199a-modified exosomes from adipose tissue-derived mesenchymal stem cells improve hepatocellular carcinoma chemosensitivity through mTOR pathway. J Exp Clin Cancer Res. 2020; 39:1-9.","DOI":"10.1186\/s13046-019-1512-5"},{"key":"256","unstructured":"256. Karaoz E, Sun E, Demir CS. Mesenchymal stem cell-derived exosomes do not promote the proliferation of cancer cells <i>in vitro<\/i>. Int J Physiol Pathophysiol Pharmacol. 2019; 11:177."},{"key":"257","doi-asserted-by":"crossref","unstructured":"257. Abas BI, Demirbolat GM, Cevik O. Wharton jelly-derived mesenchymal stem cell exosomes induce apoptosis and suppress EMT signaling in cervical cancer cells as an effective drug carrier system of paclitaxel. PloS One. 2022; 17:e0274607.","DOI":"10.1371\/journal.pone.0274607"},{"key":"258","doi-asserted-by":"crossref","unstructured":"258. Maqsood M, Kang M, Wu X, Chen J, Teng L, Qiu L. Adult mesenchymal stem cells and their exosomes: Sources, characteristics, and application in regenerative medicine. Life Sci. 2020; 256:118002.","DOI":"10.1016\/j.lfs.2020.118002"},{"key":"259","doi-asserted-by":"crossref","unstructured":"259. Mizenko RR, Feaver M, Bozkurt BT, Lowe N, Nguyen B, Huang KW, Wang A, Carney RP. A critical systematic review of extracellular vesicle clinical trials. J Extracell Vesicles. 2024; 13:e12510.","DOI":"10.1002\/jev2.12510"},{"key":"260","doi-asserted-by":"crossref","unstructured":"260. Surana R, LeBleu VS, Lee JJ, Smaglo BG, Zhao D, Lee MS, Wolff RA, Overman MJ, Mendt MC, McAndrews KM. Phase I study of mesenchymal stem cell (MSC)-derived exosomes with KRASG12D siRNA in patients with metastatic pancreatic cancer harboring a KRASG12D mutation. American Society of Clinical Oncology, 2022.","DOI":"10.1200\/JCO.2022.40.4_suppl.TPS633"},{"key":"261","doi-asserted-by":"crossref","unstructured":"261. Smaglo BG, LeBleu VS, Lee JJ, Maitra A, Kalluri R, Rezvani K, Solis Soto LM, Hurd M, Kaur I, Mendt Vilchez MC. Abstract C084: iExplore: A phase I study of mesenchymal stem cell derived exosomes with KrasG12D siRNA for metastatic pancreas cancer patients harboring the KrasG12D mutation. Cancer Res. 2024; 84:C084-C084.","DOI":"10.1158\/1538-7445.PANCA2023-C084"},{"key":"262","doi-asserted-by":"crossref","unstructured":"262. LeBleu V, Smaglo BG, Mahadevan KK, Kirtley ML, McAndrews KM, Mendt MC, Yang S, Maldonado AS, Sugimoto H, Salvatierra ME. KRASG12D-Specific Targeting with Engineered Exosomes Reprograms the Immune Microenvironment to Enable Efficacy of Immune Checkpoint Therapy in PDAC Patients. medRxiv. 2025; 2025.2003. 2003.25322827.","DOI":"10.1101\/2025.03.03.25322827"},{"key":"263","doi-asserted-by":"crossref","unstructured":"263. Besse B, Charrier M, Lapierre V, Dansin E, Lantz O, Planchard D, Le Chevalier T, Livartoski A, Barlesi F, Laplanche A. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology. 2016; 5:e1071008.","DOI":"10.1080\/2162402X.2015.1071008"},{"key":"264","doi-asserted-by":"crossref","unstructured":"264. Kamerkar S, Leng C, Burenkova O, Jang SC, McCoy C, Zhang K, Dooley K, Kasera S, Zi T, Sis\u00f3 S. Exosome-mediated genetic reprogramming of tumor-associated macrophages by exoASO-STAT6 leads to potent monotherapy antitumor activity. Sci Adv. 2022; 8:eabj7002.","DOI":"10.1126\/sciadv.abj7002"},{"key":"265","doi-asserted-by":"crossref","unstructured":"265. Wang B, Yu W, Jiang H, Meng X, Tang D, Liu D. Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects. Front Immunol. 2024; 15:1485546.","DOI":"10.3389\/fimmu.2024.1485546"},{"key":"266","doi-asserted-by":"crossref","unstructured":"266. Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med. 2005; 3:1-8.","DOI":"10.1186\/1479-5876-3-9"},{"key":"267","doi-asserted-by":"crossref","unstructured":"267. Viaud S, Terme M, Flament C, Taieb J, Andr\u00e9 F, Novault S, Escudier B, Robert C, Caillat-Zucman S, Tursz T. Dendritic cell-derived exosomes promote natural killer cell activation and proliferation: A role for NKG2D ligands and IL-15R\u03b1. PloS One. 2009; 4:e4942.","DOI":"10.1371\/journal.pone.0004942"},{"key":"268","doi-asserted-by":"crossref","unstructured":"268. Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008; 16:782-790.","DOI":"10.1038\/mt.2008.1"},{"key":"269","doi-asserted-by":"crossref","unstructured":"269. Pitt JM, Andr\u00e9 F, Amigorena S, Soria J-C, Eggermont A, Kroemer G, Zitvogel L. Dendritic cell\u2013derived exosomes for cancer therapy. J Clin Invest. 2016; 126:1224-1232.","DOI":"10.1172\/JCI81137"},{"key":"270","doi-asserted-by":"crossref","unstructured":"270. Zabeti Touchaei A, Vahidi S. MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1\/PD-L1 and CTLA-4 pathways. Cancer Cell Int. 2024; 24:102.","DOI":"10.1186\/s12935-024-03293-6"},{"key":"271","doi-asserted-by":"crossref","unstructured":"271. Ware MB, Phillips M, McQuinn C, Zaidi MY, Knochelmann HM, Greene E, Robinson B, Herting CJ, Mace TA, Chen Z. Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell\u2013and CXCR3-dependent manner. JCI insight. 2023; 8:e155006.","DOI":"10.1172\/jci.insight.155006"},{"key":"272","doi-asserted-by":"crossref","unstructured":"272. Salybekov AA, Kunikeyev AD, Kobayashi S, Asahara T. Latest advances in endothelial progenitor cell-derived extracellular vesicles translation to the clinic. Front Cardiovasc Med. 2021; 8:734562.","DOI":"10.3389\/fcvm.2021.734562"},{"key":"273","doi-asserted-by":"crossref","unstructured":"273. Escudier B, Dorval T, Chaput N, Andr\u00e9 F, Caby M-P, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial. J Transl Med. 2005; 3:1-13.","DOI":"10.1186\/1479-5876-3-10"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/19\/5\/19_2025.01120\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T04:04:12Z","timestamp":1763179452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/19\/5\/19_2025.01120\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":273,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2025.01120","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"2025.01120"}}